Anavex Life Sciences Corp (AVXL)

[pcguy]

That was not the end game for Anavex or me as an investor, and it would be wrong to price in all the other operations into rett alone. If this company is only successful in the rett indication, they should simply cut thier losses and license to a larger company that can absorb all the overhead, not paying millions to the CEO and Accountant for one small indication alone.

Anavex should price according to projected future success in at least one other indication. Revenue now helps fund future operation, but should not support all operations. Don't punish rett patients because we invested in something bigger.